Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues
09 Janeiro 2024 - 9:00AM
Business Wire
2023 revenues are expected to be approximately
$20 million above top end of guidance
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
(cfDNA) testing, today announced preliminary revenue results for
the fourth quarter and full year ended Dec. 31, 2023. The Company
expects the following:
- Total revenues of approximately $300 million in the fourth
quarter of 2023, an increase of approximately 38% compared to $217
million in the fourth quarter of 2022.
- Total revenues of approximately $1.07 billion in 2023, an
increase of approximately 30% compared to $820 million in
2022.
These results are also included in a presentation that has been
posted to the investor relations section of the Natera website at
investor.natera.com. The presentation is being delivered today, at
the 42nd Annual J.P. Morgan Healthcare Conference.
Natera plans to release its complete fourth quarter and full
year 2023 financial results during its earnings call in February
2024.
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated
to oncology, women’s health, and organ health. We aim to make
personalized genetic testing and diagnostics part of the standard
of care to protect health, and inform earlier, more targeted
interventions that help lead to longer, healthier lives. Natera’s
tests are validated by more than 180 peer-reviewed publications
that demonstrate high accuracy. Natera operates ISO 13485-certified
and CAP-accredited laboratories certified under the Clinical
Laboratory Improvement Amendments (CLIA) in Austin, Texas and San
Carlos, California. For more information, visit www.natera.com.
Forward-Looking Statements
This release contains forward-looking statements, including our
preliminary operational and financial results for the fourth
quarter and fiscal year ended December 31, 2023. The preliminary
operational and financial results for the fourth quarter and fiscal
year ended December 31, 2023 have not been audited by our
independent registered public accounting firm and are based on
management’s initial review of our operations and results for the
completed fiscal year. These preliminary operational and financial
results are subject to revision based upon our year-end closing
procedures, final adjustments and the audit to be conducted by our
independent registered public accounting firm. As a result, our
actual operational and financial results may differ materially from
these preliminary results. In addition, these preliminary
operational and financial results are not a comprehensive statement
of our operational and financial results for the fourth quarter and
for fiscal 2023, and should not be viewed as a substitute for full,
audited financial statements prepared in accordance with generally
accepted accounting principles. Any forward-looking statements
contained in this release are based upon Natera's current plans,
estimates, and expectations as of the date of this release, and are
not a representation that such plans, estimates, or expectations
will be achieved. Subsequent events may cause these expectations to
change, and Natera disclaims any obligation to update the
forward-looking statements in the future.
Our forward-looking statements are subject to known and unknown
risks and uncertainties that may cause actual results to differ
materially, including: our preliminary operational and financial
results for the fourth quarter and for fiscal 2023 are subject to
material changes and adjustments as noted above; we face numerous
uncertainties and challenges in achieving our financial projections
and goals; we have incurred losses since our inception and we
anticipate that we will continue to incur losses for the
foreseeable future; our quarterly results may fluctuate from period
to period; our estimates of market opportunity and forecasts of
market growth may prove to be inaccurate. Additional risks and
uncertainties that could affect our financial results are discussed
in greater detail in the sections titled "Risk Factors" and
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” in our most recent filings on Forms 10-K and
10-Q and in other filings that we make with the SEC from time to
time. These documents are available at www.investor.natera.com and
on the SEC’s website at www.sec.gov.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240109561596/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
510-826-2350, investor@natera.com Media: Lesley Bogdanow, VP of
Corporate Communications, Natera, Inc., pr@natera.com
Natera (NASDAQ:NTRA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Natera (NASDAQ:NTRA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024